A serious discussion was held for eliciting the problems in the manufacturing of classical Ayurveda medicine.Many classical medicines available before 15-20 years has vanished from market. This affects physician’s freedom to choose the right drug. Off course profitability is a major break point in industrial point of view . What are the major issues adversely affects manufacturing of kashayas, tailas, grithas, avarties, etc. How can we save the industry ? How can we preserve genuine Ayurveda ? What are the corrective measures to be undertaken ? The programme was successful and it could outline an action plan.
2016 November 9,Trivandrum: AMAI delegation headed by its General Secretary Dr Rejith Anand handed over the CD of Statewide activities conducted by different organs of
PHARMABIZ.COM NEWS http://www.pharmabiz.com/NewsDetails.aspx?aid=75572&sid=1 AMAI urges Kerala govt to give due importance to Ayurveda in state health policy Peethaambaran Kunnathoor, ChennaiTuesday, May 28, 2013, 08:00 Hrs
CCIM Committee for MSR Regulations Amendment The 49th meeting of the Central Council of Indian Medicine has appointed an expert committee to give suggestions on